Meeting
2022 ASCO Gastrointestinal Cancers Symposium
Definitive chemoradiotherapy for locoregional recurrence of esophageal squamous cell carcinoma patients after radical surgery: Retrospective study.
Authors
Kentaro Harada
Department of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
Kentaro Harada , Shun Yamamoto , Akihiro Ohara , Mai Itoyama , Yoshitaka Honma , Tairo Kashihara , Koji Inaba , Koshiro Ishiyama , Junya Oguma , Hiroshi Igaki , Hiroyuki Daiko , Ken Kato
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Therapeutics
DOI
10.1200/JCO.2022.40.4_suppl.314
Abstract #
314
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2015 Gastrointestinal Cancers Symposium
Comparison between neoadjuvant chemotherapy followed by surgery (NAC-S) and definitive chemoradiotherapy (CRT) in overall survival for patients with clinical stage II-III esophageal squamous cell carcinoma (ESCC) (JCOG1406-A).
First Author: Motoo Nomura
Poster
2019 Gastrointestinal Cancers Symposium
A retrospective analysis of neoadjuvant chemotherapy followed by surgery or definitive chemoradiotherapy in patients with advanced esophageal squamous cell carcinoma.
First Author: Hiroshi Nakatsumi
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Safety and short-term efficacy of neoadjuvant FLOT therapy in patients with resectable esophageal squamous cell carcinoma.
First Author: Yuri Yoshinami
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Short-term safety of adjuvant nivolumab therapy after neoadjuvant docetaxel plus cisplatin and 5-FU therapy for locally advanced esophageal squamous cell carcinoma.
First Author: Toshiharu Hirose